Fig. 5From: Delivery of cisplatin and resiquimod in nanomicelles for the chemoimmunotherapy of ovarian cancerThe effect of CDDP/resiquimod/PLG-g-mPEG on clonogenic ability of SW626 cells. 1 for control group; 2 for CDDP group; 3 for resiquimod group; 4 for PLG-g-mPEG group; 5 for CDDP/resiquimod/PLG-g-mPEG groupBack to article page